PHILIP LESLIE PENFOLD,GHOLAM ALI PEYMAN,DONALD ROBERT SANDERS
申请号：
PT05735924
公开号：
PT1755616E
申请日:
2005.04.08
申请国别(地区):
PT
年份:
2013
代理人:
摘要：
The present invention provides a method of treatment of an individual with an ophthalmic condition that may comprise the step of: administering to the individual a therapeutically effective amount of a compound capable of modulating the activity of mineralocorticoid receptors within cells or tissue located in an eye or adjacent to an eye in the individual to be treated. Preferably, said compound may be an anti-oedematous steroid, more preferably a mineralocorticoid.
